Visit our Expo - Redox and Inflammation signaling 2012

More documents

Recommendations

Info

Friday January 27th, 2006 (Evening session) 17h30 – 19h00 : Cell signaling pathways leading to regulated chromatin modifications 17h30 – 17h50 : Richard Pestell (Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA): Cyclins and HDAC/HATs 17h50 – 18h10 : Luciano Di Croce (ICREA and Centre de Regulacio Genomica (CRG), Barcelona, Spain): Targeting chromatin machines to promoters in leukemias 18h10 – 18h30 : Willem Voncken (Research Institute Growth and Development, University Maastricht, The Netherlands): Talking to chromatin: Silencers Silenced. 18h30 – 18h50 : Guy Haegeman (Laboratory for Eukaryotic Gene Expression and Signal Transduction, Department of Molecular Biology, Ghent University, Belgium): Chromatin impact on NFkB-driven gene expression 23h00 – 3h00 : Science Party at Melusina Night Club - 20 -
Saturday January 28th, 2006 (Early morning session) 7h30 – 8h30 : Cell signaling un health and disease : short communications II 7h30 – 7h40 : Réjane Paumelle (Département d’Athérosclerose, U545 Inserm, Institut Pasteur de Lille and Faculté de Pharmacie, Université de Lille II, Lille, France) : Acute anti-inflammatory properties of statins involve Peroxisome Proliferator-Activated Receptor-alpha via inhibition of the PKC signalling pathway 7h40 – 7h50 : Alexander L. Pukhalsky (Research Centre for Medical Genetics, Moscow ) : Alkylating drugs applied in non-cytotoxic doses as a novel compounds targeting inflammatory signal pathways 7h50 – 8h00 : Eric Adriaenssens (Institut Pasteur, Lille, France.) : A new antisense transcript is involved in the genomic imprinting control at the H19/IGF2 locus. 8h00 – 8h10 : Caroline Rouaux (Laboratoire de Signalisation Moléculaire et Neurodégénérescence – INSERM U692 - Faculté de Médecine, Strasbourg, France) : Inhibition of histone deacetylase activity as a therapeutic tool in amyotrophic lateral sclerosis. 8h10 - 8h20 : Peter J. van den Elsen (Leiden University Medical Center, Leiden, The Netherlands ) : Epigenic control of MHC2TA transcription: varying contributions of DNA and histone modifications in cell-activation and interferon-gamma-mediated induction of gene expression in cancer cells 8h20 – 8h30 : Joydeb Kumar Kundu (National Research Laboratory of Molecular Carcinogenesis and Chemoprevention, College of Pharmacy, Seoul National University, South Korea) : Resveratrol inhibits phorbol ester-induced expression of COX-2 through inactivation of NF- !B and AP-1 in mouse skin: role of I!B kinase and MAP kinases Saturday January 28th, 2006 (Morning session) 8h30 - 10h30: Transcriptional control 8h30 – 9h00 : Yinon Ben-Neriah (The Lautenberg Center for Immunology, Hebrew- University-Hadassah Medical School, Jerusalem, Israel): Tissue specific control of NF-kappaB activation 9h00 – 9h30 : Sankar Ghosh (Yale University School of Medicine, New Haven, CT , USA): Regulation of NF-kB-dependent transcription 9h30 – 10h00 : Moshe Oren (Department of Molecular Cell Biology, The Weizmann Institute, Rehovot, Israel): Oncogenic signaling by mutant p53 10h00 – 10h10 : Hyeyoung Kim (Department of Pharmacology and Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul 120-752, Korea) : Crosstalk between NF-kB and AP-1 in Helicobacter pylori-mediated inflammation in human gastric epithelial cells - 21 -
Page 1 and 2: - 1 - Luxembourg, January 25th to 2
Page 3 and 4: Table of content PREFACE ..........
Page 5 and 6: Preface In 1998, we organized the f
Page 7 and 8: Acknowledgments This meeting has be
Page 9 and 10: Group B (15h00 - 17h00) Session V.
Page 11 and 12: - 11 - Exhibition
Page 13 and 14: Visit our Expo (in alphabetical ord
Page 15 and 16: Thursday January 26th, 2006 (Early
Page 17 and 18: Thursday January 26th, 2006 (Evenin
Page 19: Regulation of inflammation and gluc
Page 23 and 24: Oral presentations (by alphabetical
Page 25 and 26: 4: : Lottin S, Vercoutter-Edouart A
Page 27 and 28: the B-Raf/mitogen-activated/extrace
Page 29 and 30: Albertini MC, Accorsi A, Citterio B
Page 31 and 32: AP-1-dependent gene expression in s
Page 33 and 34: Jaks and cytokine receptors - an in
Page 35 and 36: The Role of Met-Gab1 Signalling in
Page 37 and 38: The mammalian tumor suppressor Scri
Page 39 and 40: SIGNAL TRANSDUCTION BY STRESS-ACTIV
Page 41 and 42: Title to be announced Caroline Dive
Page 43 and 44: Mechanisms of DNA methylation in ma
Page 45 and 46: Blocking the "4 Integrin-Paxillin I
Page 47 and 48: Regulation of NF-kB-dependent trans
Page 49 and 50: The immunomodulator AS101 induces g
Page 51 and 52: Signaling pathways leading to the a
Page 53 and 54: Boute, N., Jockers, R. and Issad, T
Page 55 and 56: Jespsen JS, Sorensen MD and Wengel
Page 57 and 58: 8. Nishikawa, H., Kawai, K., Tanaka
Page 59 and 60: 9) Proteome analysis of rat pancrea
Page 61 and 62: MicroRNA is an anti-apoptotic facto
Page 63 and 64: Resveratrol inhibits phorbol ester-
Page 65 and 66: Cross-talk between angiotensin II a
Page 67 and 68: Multiple role of histamine H 1 rece
Page 69 and 70: PI3K Targeting by the Beta-GBP Cyto
Page 71 and 72:
D.P. Chopra, R.E. Menard, J. Janusz
Page 73 and 74:
[2] Meijer, L., Flajolet, M. and Gr
Page 75 and 76:
[4] Niemand, C., Nimmesgern, A., Ha
Page 77 and 78:
Oncogenic signaling by mutant p53 M
Page 79 and 80:
activity of the Peroxisome Prolifer
Page 81 and 82:
Restauration of SHIP-1 activity in
Page 83 and 84:
Hypoxia Signaling. Impact on Tumor
Page 85 and 86:
5. Sokolov EI, Zykov KA, Pukhalsky
Page 87 and 88:
HOW ANTITOXIC AND ANTICANCER AGENTS
Page 89 and 90:
Listeria monocytogenes induced Rac1
Page 91 and 92:
Epigenetic Regulation of Stem Cell
Page 93 and 94:
Survey on in vitro cell death induc
Page 95 and 96:
Distinct roles of IRF-3 and IRF-7 i
Page 97 and 98:
Redox-Sensitive Transcription Facto
Page 99 and 100:
Epigenic control of MHC2TA transcri
Page 101 and 102:
Attenuation of MSK1-driven NF-kB ge
Page 103 and 104:
Talking to chromatin: Silencers Sil
Page 105 and 106:
Ubiquitin ligase Smurf1 controls os
Page 107 and 108:
Workshop presentations (by alphabet
Page 109 and 110:
Ambion MicroRNAs (miRNAs) are small
Page 111 and 112:
Organizer: BIOBASE GmbH Date: Janua
Page 113 and 114:
Reliable and efficient gene Knock-d
Page 115 and 116:
Exploring ubiquitin signaling with
Page 117 and 118:
Poster presentations Poster are cla
Page 119 and 120:
Session I : protein domains Poster
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Notes Notes - 125 -
Page 127 and 128:
Session II. Receptor signaling and
Page 129 and 130:
Session II : Receptor signaling and
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Notes Notes - 181 -
Page 183 and 184:
Session III. Protein kinase cascade
Page 185 and 186:
Session III : Protein kinase cascad
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Notes Notes - 255 -
Page 257 and 258:
Session IV. Protein kinase inhibito
Page 259 and 260:
IV. Protein kinase inhibitors: insi
Page 261 and 262:
IV. Protein kinase inhibitors: insi
Page 263 and 264:
Notes - 263 -
Page 265 and 266:
- 265 -
Page 267 and 268:
V. Phosphatases as key cell signali
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Notes - 273 -
Page 275 and 276:
- 275 -
Page 277 and 278:
VI. Proteasome degradation pathways
Page 279 and 280:
VI. Proteasome degradation pathways
Page 281 and 282:
Session VII. Stem cell specific cel
Page 283 and 284:
Notes - 283 -
Page 285 and 286:
VIII. Inflammation specific signali
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Page 313 and 314:
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321 and 322:
Notes - 321 -
Page 323 and 324:
- 323 -
Page 325 and 326:
Session IX. Novel compounds targeti
Page 327 and 328:
Page 329 and 330:
Page 331 and 332:
Page 333 and 334:
Session X : Cell death in cancer -
Page 335 and 336:
Session X : Cell death in cancer Po
Page 337 and 338:
Page 339 and 340:
Page 341 and 342:
Page 343 and 344:
Page 345 and 346:
Page 347 and 348:
Page 349 and 350:
Page 351 and 352:
Page 353 and 354:
Page 355 and 356:
Page 357 and 358:
Page 359 and 360:
Page 361 and 362:
Page 363 and 364:
Page 365 and 366:
Page 367 and 368:
Page 369 and 370:
Page 371 and 372:
Page 373 and 374:
Page 375 and 376:
Page 377 and 378:
Page 379 and 380:
Page 381 and 382:
Page 383 and 384:
Page 385 and 386:
Page 387 and 388:
Page 389 and 390:
Page 391 and 392:
Page 393 and 394:
Page 395 and 396:
Page 397 and 398:
Page 399 and 400:
Page 401 and 402:
Page 403 and 404:
Page 405 and 406:
Page 407 and 408:
Page 409 and 410:
Page 411 and 412:
Page 413 and 414:
Page 415 and 416:
Page 417 and 418:
Page 419 and 420:
Page 421 and 422:
Page 423 and 424:
Page 425 and 426:
Page 427 and 428:
Page 429 and 430:
Page 431 and 432:
Page 433 and 434:
Page 435 and 436:
Page 437 and 438:
Page 439 and 440:
Page 441 and 442:
Page 443 and 444:
Notes Notes - 443 -
Page 445 and 446:
Session XI : Cell death and cardiov
Page 447 and 448:
Session XI: Cell death and cardiova
Page 449 and 450:
Page 451 and 452:
Page 453 and 454:
Page 455 and 456:
Page 457 and 458:
Notes - 457 -
Page 459 and 460:
Session XII : Cell death and neurod
Page 461 and 462:
Page 463 and 464:
Page 465 and 466:
Page 467 and 468:
Page 469 and 470:
Page 471 and 472:
Page 473 and 474:
Page 475 and 476:
Page 477 and 478:
Page 479 and 480:
Page 481 and 482:
Page 483 and 484:
Page 485 and 486:
Notes - 485 -
Page 487 and 488:
- 487 -
Page 489 and 490:
Session XIII : Cell signaling pathw
Page 491 and 492:
Page 493 and 494:
Page 495 and 496:
Page 497 and 498:
Page 499 and 500:
Page 501 and 502:
Notes Notes - 501 -
Page 503 and 504:
Session XIV : Transcriptional and t
Page 505 and 506:
Page 507 and 508:
Page 509 and 510:
Page 511 and 512:
Page 513 and 514:
Page 515 and 516:
Page 517 and 518:
Page 519 and 520:
Page 521 and 522:
Page 523 and 524:
Page 525 and 526:
Page 527 and 528:
Page 529 and 530:
Page 531 and 532:
Page 533 and 534:
Page 535 and 536:
Page 537 and 538:
Page 539 and 540:
Page 541 and 542:
Page 543 and 544:
Page 545 and 546:
Page 547 and 548:
Page 549 and 550:
Page 551 and 552:
Page 553 and 554:
Page 555 and 556:
Page 557 and 558:
Page 559 and 560:
Page 561 and 562:
Page 563 and 564:
Page 565 and 566:
Page 567 and 568:
Page 569 and 570:
Page 571 and 572:
Page 573 and 574:
Page 575 and 576:
Page 577 and 578:
Page 579 and 580:
Page 581 and 582:
Page 583 and 584:
Notes Notes - 583 -
Page 585 and 586:
Session XV : Reactive oxygen specie
Page 587 and 588:
Page 589 and 590:
Page 591 and 592:
Notes - 591 -
Page 593 and 594:
Session XVI : Chemopreventive agent
Page 595 and 596:
Page 597 and 598:
Page 599 and 600:
Page 601 and 602:
Page 603 and 604:
Page 605 and 606:
Page 607 and 608:
Session XVII : Cell signaling in he
Page 609 and 610:
Page 611 and 612:
Page 613 and 614:
Page 615 and 616:
Page 617 and 618:
Page 619 and 620:
Page 621 and 622:
Page 623 and 624:
Page 625 and 626:
Page 627 and 628:
Page 629 and 630:
Page 631 and 632:
Page 633 and 634:
Page 635 and 636:
Page 637 and 638:
Page 639 and 640:
Page 641 and 642:
Page 643 and 644:
Page 645 and 646:
Page 647 and 648:
Page 649 and 650:
Page 651 and 652:
Page 653 and 654:
Page 655 and 656:
Page 657 and 658:
Page 659 and 660:
Page 661 and 662:
Page 663 and 664:
Page 665 and 666:
Page 667 and 668:
Page 669 and 670:
Notes - 669 -
Page 671 and 672:
- 671 -
Page 673 and 674:
- 673 -
Page 675 and 676:
Dr. Nassera Aouali L-1526 Luxembour
Page 677 and 678:
Dr. Giordano Bianchi Clinic of inte
Page 679 and 680:
Mrs. Isabel Burghardt Laboratory of
Page 681 and 682:
Pr. Czeslaw Cierniewski 92-215 Lodz
Page 683 and 684:
Mr. Igotz Delgado Biochemistry 4894
Page 685 and 686:
Mrs. Anissa Fergani INSERM U-692 67
Page 687 and 688:
Dr. Mark Ginsberg Mail code 0726 92
Page 689 and 690:
Dr. Jochen Hefl Division of Signal
Page 691 and 692:
Mr. Jan Jepsen 2100 Copenhagen DNK
Page 693 and 694:
Pr. Young Min Kim Division of Biolo
Page 695 and 696:
Mr. Christoph Lahtz AG Tumorgenetik
Page 697 and 698:
Pr. Etta Livneh 84105 Beer Sheva IS
Page 699 and 700:
Mrs. Rasa Merzvinskyte Department o
Page 701 and 702:
Mr. Gustav Nilsonne Department of L
Page 703 and 704:
Mrs. Christel Péqueux Tumour and D
Page 705 and 706:
Dr. Gabriella Regis Tumor Immunolog
Page 707 and 708:
Dr. Carsten Scheller 97078 Wuerzbur
Page 709 and 710:
Mr. Yoo-Cheol Song Laboratory of Gy
Page 711 and 712:
Dr. Lucia Maria Valatro Laboratori
Page 713 and 714:
Mrs. Jessica Wagener 40225 Duesseld
Page 715:
Pr. Moncef ZOUALI Centre Viggo Pete
show all

Visit our Expo - Redox and Inflammation signaling 2012

Create successful ePaper yourself

Delete template?

Save as template?